FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Pantoprazole (Protonix) Powder for Injection
Status: Currently in Shortage
»Date first posted: 06/21/2017
»Therapeutic Categories: Gastroenterology; Pediatric

Expand all

AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.) (Revised 07/20/2017)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
AuroMedics Pantoprazole Sodium for Injection, 40 mg (packages of 10) (NDC 55150-202-10) Product currently on backorder. Regular shipments are ongoing from additional packaging line and lyophilization equipment as well as from the original packaging line and lyophilization equipment. In coordination with the U.S. Food and Drug Administration, AuroMedics Pharma is distributing Pantoprazole Sodium for Injection mfd. by Aurobindo Pharma Ltd. using an additional packaging line and lyophilization equipment not yet approved by the FDA.

Dear Healthcare Professional Letter

Demand increase for the drug

Pfizer Pharmaceuticals (Revised 07/21/2017)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Protonix 40mg Vial 25's (NDC 0008-0923-60) Next delivery: Late July 2017; Estimated recovery: 1Q 2018 Shortage per manufacturer: Manufacturing delay Other
Protonix 40mg Vial 10's (NDC 0008-0923-55) Next delivery: Late July; Estimated recovery: 1Q 2018 Shortage per manufacturer: Manufacturing delay Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English